STOCK TITAN

HealthStream Inc (HSTM) Financials

HSTM
Trailing 12 months to June 30, 2026
Revenue $321.1M +8.8% YoY
Net Income $21.2M +4.3% YoY
EPS (Diluted) $0.72 +7.5% YoY
Free Cash Flow $69.8M +19.3% YoY
Market Cap $1.0B as of Oct 13, 2026
Price / Sales 3.2x on $321.1M revenue, trailing 12 months to June 30, 2026
Price / Earnings 48.7x on $21.2M net income, trailing 12 months to June 30, 2026
Price / Book 2.9x on $356.6M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HSTM SEC filings page.

HealthStream Inc (HSTM) reported $321.1M in revenue over the twelve months to Jun 30, 2026, up 8.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HSTM FY2025

HealthStream converts modest growth into cash, but 2025 margin compression and tighter working-capital coverage show growth is not fully reaching profit.

Cash conversion is stronger than earnings alone suggest: across FY2023-FY2025, free cash flow exceeded net income every year. In FY2025, free cash flow of $59.6M versus net income of $18.3M means accounting profit is a poor standalone proxy for cash generation.

Margin shape weakened even as revenue advanced: FY2025 revenue reached $304.1M while gross margin eased to 64.7%. Operating margin fell from 7.3% in FY2024 to 6.7% in FY2025, so the latest growth came with less operating conversion rather than expanding profitability.

Short-term balance-sheet flexibility narrowed: the current ratio dropped from 1.3x in FY2024 to 1.0x in FY2025. Current liabilities rose to $124.1M even as the company repurchased $30.0M of stock; that combination leaves less short-term cushion for discretionary capital allocation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 55 / 100
Financial Health Score 55/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of HealthStream Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
60

HealthStream Inc has an operating margin of 6.7%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 60/100, indicating healthy but not exceptional operating efficiency. This is down from 7.3% the prior year.

Growth
47

HealthStream Inc's revenue grew a modest 4.3% year-over-year to $304.1M. This slow but positive growth earns a score of 47/100.

Leverage
62

HealthStream Inc has a moderate D/E ratio of 0.47. This balance of debt and equity financing earns a leverage score of 62/100.

Liquidity
17

HealthStream Inc's current ratio of 0.96 is below the typical benchmark, resulting in a score of 17/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
86

HealthStream Inc converts 19.6% of revenue into free cash flow ($59.6M). This strong cash generation earns a score of 86/100.

Returns
55

HealthStream Inc's ROE of 5.2% shows moderate profitability relative to equity, earning a score of 55/100. This is down from 5.6% the prior year.

Altman Z-Score Safe
4.76

HealthStream Inc scores 4.76, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.0B) relative to total liabilities ($166.4M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

HealthStream Inc passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
3.45x

For every $1 of reported earnings, HealthStream Inc generates $3.45 in operating cash flow ($63.3M OCF vs $18.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$83.7M
YoY+12.5%
QoQ+3.1%
5Y CAGR+5.3%
10Y CAGR+4.3%

HealthStream Inc generated $83.7M in revenue in Q2 2026. This represents an increase of 12.5% from the same quarter a year earlier. Against the prior quarter it is up 3.1%.

EBITDA
$19.6M
YoY+17.0%
QoQ+3.8%
5Y CAGR+9.3%
10Y CAGR+10.2%

HealthStream Inc's EBITDA was $19.6M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.0% from the same quarter a year earlier. Against the prior quarter it is up 3.8%.

Net Income
$6.7M
YoY+23.8%
QoQ+12.8%
5Y CAGR+22.3%
10Y CAGR+16.9%

HealthStream Inc reported $6.7M in net income in Q2 2026. This represents an increase of 23.8% from the same quarter a year earlier. Against the prior quarter it is up 12.8%.

EPS (Diluted)
$0.23
YoY+27.8%
QoQ+15.0%
5Y CAGR+23.5%
10Y CAGR+19.1%

HealthStream Inc earned $0.23 per diluted share (EPS) in Q2 2026. This represents an increase of 27.8% from the same quarter a year earlier. Against the prior quarter it is up 15.0%.

Cash & Balance Sheet

Free Cash Flow
$12.5M
YoY+362.7%
QoQ-52.6%
5Y CAGR+21.6%

HealthStream Inc generated $12.5M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 362.7% from the same quarter a year earlier. Against the prior quarter it is down 52.6%.

Cash & Debt
$46.2M
YoY-11.4%
QoQ-5.2%
5Y CAGR-1.5%
10Y CAGR-3.6%

HealthStream Inc held $46.2M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share
$0.04
YoY+12.9%
QoQ0.0%

HealthStream Inc paid $0.04 per share in dividends in Q2 2026. This represents an increase of 12.9% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
29M
YoY-1.4%
QoQ+0.1%
5Y CAGR-1.5%
10Y CAGR-0.8%

HealthStream Inc had 29M shares outstanding in Q2 2026. This represents a decrease of 1.4% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Gross Margin
65.3%
YoY+0.8pp
QoQ-0.5pp
5Y change+0.3pp

HealthStream Inc's gross margin was 65.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.

Operating Margin
9.9%
YoY+2.0pp
QoQ+0.7pp
5Y change+4.7pp
10Y change+5.7pp

HealthStream Inc's operating margin was 9.9% in Q2 2026, reflecting core business profitability. This is up 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Net Margin
8.0%
YoY+0.7pp
QoQ+0.7pp
5Y change+4.2pp
10Y change+5.4pp

HealthStream Inc's net profit margin was 8.0% in Q2 2026, showing the share of revenue converted to profit. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Return on Equity
1.9%
YoY+0.3pp
QoQ+0.2pp
5Y change+1.2pp
10Y change+1.4pp

HealthStream Inc's ROE was 1.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Capital Allocation

R&D Spending
$13.6M
YoY+12.5%
QoQ-0.2%
5Y CAGR+5.6%
10Y CAGR+6.5%

HealthStream Inc invested $13.6M in research and development in Q2 2026. This represents an increase of 12.5% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Share Buybacks
$2.6M
YoY-85.7%
QoQ-61.6%

HealthStream Inc spent $2.6M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 85.7% from the same quarter a year earlier. Against the prior quarter it is down 61.6%.

Capital Expenditures
$910K
YoY-60.7%
QoQ+23.0%
5Y CAGR+12.3%
10Y CAGR+5.2%

HealthStream Inc invested $910K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 60.7% from the same quarter a year earlier. Against the prior quarter it is up 23.0%.

HSTM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSTM quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$83.7M+12.5%$81.2M+10.5%$79.7M+7.4%$76.5M+4.6%$74.4M+4.0%$73.5M+1.0%$74.2M+5.2%$73.1M+3.9%
Cost of Revenue$29.0M+10.1%$27.8M+8.9%$28.9M+14.9%$26.5M+8.3%$26.4M+11.1%$25.5M+3.5%$25.1M+4.6%$24.5M+3.7%
Gross Profit$54.7M+13.9%$53.4M+11.3%$50.9M+3.5%$50.0M+2.8%$48.0M+0.4%$48.0M-0.3%$49.1M+5.5%$48.6M+4.0%
R&D Expenses$13.6M+12.5%$13.6M+12.9%$14.8M+16.4%$12.1M+0.1%$12.1M0.0%$12.0M+0.1%$12.7M+6.3%$12.1M+11.0%
Operating Income$8.3M+41.4%$7.5M+71.6%$2.4M-48.7%$7.6M+16.5%$5.9M+33.4%$4.4M-23.1%$4.7M+10.1%$6.5M+33.6%
EBITDA$19.6M+17.0%$18.9M+24.7%$13.4M-11.3%$18.4M+11.0%$16.8M+13.3%$15.1M-5.6%$15.2M+2.5%$16.6M+8.5%
Income Tax$2.0M+37.1%$1.9M+108.5%$316K-46.8%$2.2M+23.5%$1.5M+30.6%$916K-30.4%$594K-28.2%$1.8M+10.6%
Net Income$6.7M+23.8%$5.9M+36.4%$2.5M-48.1%$6.1M+6.3%$5.4M+29.3%$4.3M-17.1%$4.9M+6.5%$5.7M+48.0%
EPS (Basic)$0.23+27.8%$0.20+42.9%$0.09-43.8%$0.20+5.3%$0.18+28.6%$0.14-17.6%$0.16+6.7%$0.19+46.2%
EPS (Diluted)$0.23+27.8%$0.20+42.9%$0.09-43.8%$0.20+5.3%$0.18+28.6%$0.14-17.6%$0.16+6.7%$0.19+46.2%
Diluted Shares (Avg)29M-3.7%29M-3.8%N/A30M-2.5%30M-0.2%31M+0.6%N/A31M-0.6%

Not reported in any period shown, so not listed: SG&A Expenses, Interest Expense.

HSTM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSTM quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$521.6M+4.3%$527.4M+0.6%$520.4M+1.9%$499.9M-0.6%$500.1M+0.1%$524.0M+2.4%$510.8M+2.2%$502.8M+1.0%
Current Assets$130.2M-9.8%$133.0M-21.6%$119.7M-21.9%$147.6M+1.3%$144.4M+3.8%$169.7M+15.1%$153.1M+17.6%$145.6M+14.8%
Cash & Equivalents$46.2M-11.4%$48.7M-37.0%$36.2M-39.2%$53.5M-6.9%$52.1M+12.9%$77.3M+47.5%$59.5M+47.4%$57.5M+30.3%
Short-Term Investments$20.6M-46.6%$17.8M-50.6%$20.8M-44.8%$39.0M+4.4%$38.5M+4.5%$36.0M+15.2%$37.7M+22.6%$37.4M+35.1%
Accounts Receivable$31.1M+15.7%$38.4M+24.6%$32.2M+6.5%$27.7M+5.1%$26.9M-15.3%$30.8M-22.2%$30.2M-12.1%$26.3M-12.8%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$212.7M+10.9%$212.7M+11.2%$217.5M+13.8%$191.6M+0.3%$191.8M+0.5%$191.2M+0.1%$191.2M-0.1%$191.1M+0.1%
Total Liabilities$165.0M+10.3%$175.4M+8.8%$166.4M+9.9%$150.7M+2.3%$149.6M-0.5%$161.2M-3.3%$151.4M-4.9%$147.3M-5.4%
Current Liabilities$122.6M+6.3%$136.5M+8.5%$124.1M+7.3%$112.5M+1.7%$115.4M+3.1%$125.9M-0.2%$115.7M-2.3%$110.6M-3.5%
Non-Current Liabilities$42.4M+23.8%$38.9M+10.1%$42.2M+18.2%$38.2M+4.0%$34.2M-11.1%$35.4M-13.1%$35.7M-12.5%$36.8M-10.8%
Total Equity$356.6M+1.7%$352.0M-3.0%$354.0M-1.5%$349.2M-1.8%$350.6M+0.4%$362.8M+5.2%$359.4M+5.5%$355.5M+3.9%
Retained Earnings$134.1M+14.8%$128.5M+14.3%$123.6M+13.4%$122.0M+16.2%$116.8M+16.7%$112.4M+16.1%$109.0M+18.0%$104.9M+18.5%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

HSTM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSTM quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$13.4M+167.4%$27.1M+0.2%$13.2M+18.2%$18.0M-5.7%$5.0M-22.1%$27.1M+29.3%$11.2M-19.2%$19.1M-22.5%
Depreciation & Amortization$11.3M+3.8%$11.4M+5.7%$11.0M+5.5%$10.8M+7.4%$10.9M+4.8%$10.8M+4.1%$10.5M-0.6%$10.1M-3.2%
Stock-Based Compensation$1.1M+32.3%$1.3M+18.6%N/A$794K-29.8%$836K-23.6%$1.1M+4.2%N/A$1.1M+9.0%
Capital Expenditures$910K-60.7%$740K-29.9%$204K+0.5%$109K-61.6%$2.3M+1247.1%$1.1M+42.2%$203K-41.3%$284K-39.8%
Free Cash Flow$12.5M+362.7%$26.4M+1.4%$13.0M+18.5%$17.9M-4.8%$2.7M-56.9%$26.0M+28.8%$11.0M-18.6%$18.8M-22.2%
Investing Cash Flow-$11.9M-6.6%-$6.3M+12.9%-$23.3M-188.9%-$8.6M-25.8%-$11.2M+6.4%-$7.2M-1.8%-$8.1M+14.0%-$6.9M-75.2%
Financing Cash Flow-$4.0M+79.0%-$8.3M-314.0%-$7.2M-601.3%-$7.9M-760.8%-$19.1M-2125.6%-$2.0M-18.1%-$1.0M+87.5%-$922K+62.1%
Dividends Paid$1.0M+8.4%$1.0M+9.0%$891K+4.9%$919K+8.0%$947K+11.3%$943K+11.1%$849K+6.3%$851K+11.0%
Share Buybacks$2.6M-85.7%$6.7M$5.0M$6.9M$18.1M$0$0-100.0%$0-100.0%

HSTM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HSTM quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin65.3%+0.8pp65.8%+0.5pp63.8%-2.4pp65.3%-1.2pp64.6%-2.3pp65.3%-0.8pp66.2%+0.2pp66.5%+0.1pp
Operating Margin9.9%+2.0pp9.3%+3.3pp3.0%-3.3pp9.9%+1.0pp7.9%+1.8pp6.0%-1.9pp6.3%+0.3pp8.9%+2.0pp
Net Margin8.0%+0.7pp7.3%+1.4pp3.2%-3.4pp8.0%+0.1pp7.2%+1.4pp5.9%-1.3pp6.6%+0.1pp7.8%+2.3pp
Return on Equity1.9%+0.3pp1.7%+0.5pp0.7%-0.6pp1.7%+0.1pp1.5%+0.3pp1.2%-0.3pp1.4%0.0pp1.6%+0.5pp
Return on Assets1.3%+0.2pp1.1%+0.3pp0.5%-0.5pp1.2%+0.1pp1.1%+0.3pp0.8%-0.2pp1.0%0.0pp1.1%+0.4pp
Current Ratio1.06-0.2x0.97-0.4x0.96-0.4x1.310.0x1.250.0x1.35+0.2x1.32+0.2x1.32+0.2x
Debt-to-Equity0.460.0x0.50+0.1x0.470.0x0.430.0x0.430.0x0.440.0x0.420.0x0.410.0x
Asset Turnover0.160.0x0.150.0x0.150.0x0.150.0x0.150.0x0.140.0x0.150.0x0.150.0x
FCF Margin14.9%+11.3pp32.5%-2.9pp16.3%+1.5pp23.4%-2.3pp3.6%-5.1pp35.4%+7.7pp14.8%-4.3pp25.8%-8.6pp

Note: The current ratio is below 1.0 (0.96), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
HealthStream Inc HSTM FY2025 $304.1M $18.3M 6.0% $1.0B 55/100
Evolent Health, Inc EVH FY2025 $1.9B -$579.4M -30.9% $480.5M 21/100
Weave Communications, Inc. WEAV FY2025 $239.0M -$28.1M -11.7% $593.7M 43/100
Performant Healthcare, Inc. PHLT FY2024 $123.0M -$9.9M -8.1% $623.4M 56/100
Omnicell Inc OMCL FY2025 $1.2B $2.1M 0.2% $1.7B 42/100
Phreesia, Inc. PHR FY2026 $480.6M $2.3M 0.5% $671.6M 45/100

Frequently Asked Questions

What is HealthStream Inc's annual revenue?

HealthStream Inc (HSTM) reported $304.1M in total revenue for fiscal year 2025. This represents a 4.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is HealthStream Inc's revenue growing?

HealthStream Inc (HSTM) revenue grew by 4.3% year-over-year, from $291.6M to $304.1M in fiscal year 2025.

Is HealthStream Inc profitable?

Yes, HealthStream Inc (HSTM) reported a net income of $18.3M in fiscal year 2025, with a net profit margin of 6.0%.

HealthStream Inc (HSTM) reported diluted earnings per share of $0.61 for fiscal year 2025. This represents a -7.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

HealthStream Inc (HSTM) had EBITDA of $63.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

HealthStream Inc (HSTM) had a gross margin of 64.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

HealthStream Inc (HSTM) had an operating margin of 6.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

HealthStream Inc (HSTM) had a net profit margin of 6.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, HealthStream Inc (HSTM) paid $0.12 per share in dividends during fiscal year 2025.

HealthStream Inc (HSTM) has a return on equity of 5.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

HealthStream Inc (HSTM) generated $59.6M in free cash flow during fiscal year 2025. This represents a 6.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

HealthStream Inc (HSTM) generated $63.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

HealthStream Inc (HSTM) had $520.4M in total assets as of fiscal year 2025, including both current and long-term assets.

HealthStream Inc (HSTM) invested $3.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

HealthStream Inc (HSTM) invested $51.0M in research and development during fiscal year 2025.

Yes, HealthStream Inc (HSTM) spent $30.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

HealthStream Inc (HSTM) had 29M shares outstanding as of fiscal year 2025.

HealthStream Inc (HSTM) had a current ratio of 0.96 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

HealthStream Inc (HSTM) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

HealthStream Inc (HSTM) had a return on assets of 3.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

HealthStream Inc (HSTM) trades at 48.7x earnings, its market capitalization divided by net income of $21.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

HealthStream Inc (HSTM) trades at 3.2x sales, its market capitalization divided by revenue of $321.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.0B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

HealthStream Inc (HSTM) has an Altman Z-Score of 4.76, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

HealthStream Inc (HSTM) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

HealthStream Inc (HSTM) has an earnings quality ratio of 3.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

HealthStream Inc (HSTM) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top